US Patent Application No: 2003/0073,669

Number of patents in Portfolio can not be more than 2000

N-heterocyclic derivatives as NOS inhibitors

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

N-Heterocyclic derivatives of the formula (I): 1 are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing these compounds are also described herein.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
BERLEX LABORATORIES, INC.RICHMOND, CA80
PHARMACOPEIA DRUG DISCOVERY, INC.CRANBURY, NJ96

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arnaiz, Damian O El Sobrante, CA 35 208
Baldwin, John J Gwynedd Valley, PA 251 1430
Davey, David D El Sobrante, CA 51 472
Devlin, James J Foster City, CA 68 115
Dolle, Roland Ellwood III King of Prussia, PA 11 1
Erickson, Shawn David Leonia, NJ 49 157
McMillan, Kirk Trenton, NJ 21 46
Morrissey, Michael M Danville, CA 88 1206
Ohlmeyer, Michael HJ Plainsboro, NJ 9 94
Pan, Gonghua Groton, CT 26 37
Paradkar, Vidyadhar Madhav Somerville, NJ 20 34
Parkinson, John Martinez, CA 29 55
Phillips, Gary B Pleasant Hill, CA 61 553
Ye, Bin Moraga, CA 62 188
Zhao, Zuchun Pleasanton, CA 73 306

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
PHARMACOPEIA, LLC (1)
6,919,347 Bradykinin B1 receptor antagonists 0 2002